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To determine whether West Nile virus (WNV) had
reached the archipelago of Guadeloupe, a serologic study
in horses and birds was conducted in 2002.
Immunoglobulin (Ig) G, IgM, enzyme-linked immunosorbent
assay, and seroneutralization tests identified WNV infection
in horses and chickens. Six months later, a high rate of
seroconversion was observed in horses.
W
est Nile virus (WNV) was first detected on the
American continent during an encephalitis outbreak
in birds in New York City in September 1999 (1). Since
then, analysis of surveillance data from 2000 to 2002
chronicles the spread of the infection to the South and the
West. Infection spread to Florida, Louisiana, and the
Cayman Islands in 2001 (2,3) and to northern Mexico in
2002 (4). Resident birds tested positive for WNV in
Jamaica in 2002 (5), but the infection has not yet been
observed in Lesser Antilles. This division of the French
Indies is on the migratory route of wild birds (6), which are
the most common vehicles for transmitting the virus over
long distances (7). Therefore, a study with the objective of
detecting the early appearance of the infection was planned
in Guadeloupe on susceptible species (birds and horses)
during the summer of 2002.
The Study
A passive surveillance system of encephalitis in equine
and avian species was set up to detect any occurrence of
clinical signs of WNV infection. At the same time, a sero-
logic investigation for WNV was conducted in
Guadeloupe archipelago. A cross-sectional study was per-
formed on the most susceptible animal species (birds and
horses).
The survey on birds was performed in July 2002 on St.
Martin/St. Maarten Island (63°5′-18°5′) on domestic
ducks (Family: Anatidae, Anas species), domestic geese
(Family:  Anatidae, Anser sp.), and on laughing gulls
(Larus atricilla), a resident wild species. The French part
of the island belongs to Guadeloupe’s archipelago and is
located 270 km north of the main island. It is a major rest-
ing place for migratory birds, which spend some days or
weeks on the ponds before migrating south in the fall (or
north in the spring). Therefore, St. Martin was chosen to
increase the probability of detecting the earliest serologic
conversions on resident birds and to prove the circulation
of WNV among resident birds and domestic avian species.
A total of 50 ducks and geese from four backyards as well
as ducks from the St. Maarten Zoological and Botanical
Park were sampled. On a pond, three gulls were caught
and released after blood collection.
On Guadeloupe island (61°30′-16°15′), blood samples
were drawn from 20 chickens from two different farms
neighboring a horse-riding center in December 2002. The
survey on horses was planned to be as exhaustive as possi-
ble in Guadeloupe and the nearby island of Marie Galante
(61°15′-15°55′). Serum samples from 360 of 400 horses
thought to live in Guadeloupe were collected in July 2002
(Figure). In locations where positive horses were detected
during the first survey, another sampling was drawn from
horses from December 2002 to January 2003 to measure
the rate of serologic conversion and the incidence of the
infection.
Enzyme-linked immunosorbent assays (ELISA) were
performed to detect specific immunoglobulin (Ig) G anti-
bodies to WNV in horses, ducks, geese, and chickens.
Additional immunocapture IgM ELISA was performed on
horses positive for WNV by IgG ELISA(8). Most positive
serum samples were tested by plaque reduction neutraliza-
tion test (PRNT 80) for both WNV and St. Louis
encephalitis virus (SLEV).
All the birds (36 ducks, 14 geese, and 3 gulls) sampled
from five farms and one pond in St. Maarten at the end of
July 2002 tested negative for WNV by IgG ELISA (the
ELISA test for the gulls has not been validated). In July
2002, 10 of 360 horses tested positive for WNV by IgG
ELISA, and 2 of them were also positive by IgM ELISA.
Seropositive horses were located in four different places,
two in Guadeloupe and two in Marie Galante.
The results of the survey undertaken in December 2002
to January 2003 in equine centers where positive animals
were detected in July 2002 indicated a high rate of WNV
seroconversion in horses in these locations (Table 1). In
July 2002, the overall WNV prevalence rate (IgG ELISA)
was 2.8%, reaching 10.4% in places where infected horses
were found (locations A, B, C, D). In January 2003, in
these and related places (where some horses were moved
from the former areas in July 2002), the prevalence rate
increased to 50%. On paired samples, 54 of 114 horses that
tested negative in July 2002 were positive in January 2003.
This finding represents a seroconversion of 47.4% within
6 months. The incidence rate calculated for the places
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In December 2002 and January 2003, no IgM antibodies
were detected on horses positive by IgG ELISA.
Chickens were collected from two backyards (10 chick-
ens in each place) neighboring one horse-riding club where
positive animals were detected. Eleven of these chickens
tested positive by IgG ELISA in December 2002.
To confirm the specificity of the results, positive hors-
es samples were tested by PRNT against WNV and SLEV;
all the animals showed a higher titer for WNV than for
SLEV (Table 2). Specimens from 7 of 10 horses were con-
sidered positive for WNV by ELISA. Four chicken serum
samples were tested by seroneutralization and confirmed
positive for WNV.
Conclusions
The serologic survey conducted on horses indicated an
active focus of WNV infection in Guadeloupe, probably
linked to the first infestation of the archipelago by the
virus. The absence of IgM antibodies in horses at the end
of 2002 indicates that the seroconversions did not occur
during the last weeks of the year but earlier. These results
(i.e., the presence of IgM antibodies in 2 of 10 positive ani-
mals in July 2002) suggest that the first WNV infections in
horses probably occurred during the first 6 months of 2002
and spread in the equine population in the middle of the
year.
When birds migrate, they cross the Lesser Antilles (6).
A migratory bird, infected before leaving North America
or the Caribbean Islands, may develop viremia when
reaching St. Martin, Marie Galante, or Guadeloupe islands
and transmit the virus to mosquito vectors during the rest-
ing period. Migratory birds from the North usually arrive
in Guadeloupe later than July; thus, the infection observed
in horses in July 2002 was probably not derived from
migrating birds that year. WNV was probably introduced
into Guadeloupe in the fall of 2001. After one or more
introductions, the virus may have gradually spread in the
local vector populations and amplified in resident birds
even over the winter, when vectors are still active in the
Caribbean. Then, 6 months later, the virus spread to sus-
ceptible species (horses), in which it was first detected.
In Guadeloupe, both animal and human surveillance
systems have been set up and are interacting to detect virus
circulation. In that respect, the surveillance of susceptible
animal species can provide important indicators for the
possible appearance of the disease in humans. As shown in
the United States, the death of wild birds is a pertinent
indicator for human risk (9). In avian species, mortality
and sentinel surveillance has thus been set up. Abnormal
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Figure. Location of Guadeloupe archipelago within the Caribbean.
Insert: locations of horse and chicken sampling places in
Guadeloupe and Marie Galante Islands. Red triangle, farm with
seropositive chicken; blue circle, equine center with seropositive
horses identified from July 2002; gold circle, equine center with
seropositive horses identified from December 2002 to January
2003; black circle, equine center with no seropositive horses.
Table 1. West Nile virus IgG
a antibody prevalence in horses in seven equine centers, Guadeloupe and Marie Galante, July 2002–
January 2003 
Place  No. tested July 2002  Positive  Prevalence %  No. tested Jan 2003  Positive  Prevalence %  Seroconversion rate % 
A  25  1  4.0  23  14  60.9  59.1 
B  51  2  3.9  44  27  61.4  59.5 
C  7  2  28.6  7  5  71.4  60.0 
D  13  5  38.5  12  7  58.3  28.5 
E        10
b  2  20.0   
F        2
b  2  100.0   
G  4  0  0.0  5  3  60.0  60.0 
H  7  0  0.0  9  3  33.3  33.3 
I  6  0  0.0  24  5  20.8  20.8 
Total  113  10  8.8  136  68  50.0   
aIgG, immunoglobulin G. 
bImported after July 2002. death counts have not yet been observed. This could be
related to the absence in Guadeloupe of species known to
be extremely susceptible to the infection (Corvidae), vec-
tor competence, or the virus strain. A random survey is
being implemented on domestic birds to assess the geo-
graphic distribution of the infection, in June through July
2003 (beginning of the rainy season), when populations of
vectors increase markedly in Guadeloupe. A new serolog-
ic prevalence survey in horses is also in process, and clin-
ical surveillance is ongoing. Despite a high rate of
WNV-seropositive animals, no clinical disease has been
observed. This situation could be related to the virus titer,
the rate of infected vectors (which could be too low during
the first year after WNV is introduced), or the virus strain.
In 2003, mosquito surveillance was implemented in places
where deaths in birds or encephalitis cases in horses were
observed. Virus detection using reverse transcription–
polymerase chain reaction will be used in our laboratory to
test dead birds and pools of mosquitoes. These surveys are
intended to provide the public health services with distri-
bution and prevalence maps.
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Table 2. Results of neutralization tests for antibody to WNV and 
SLEV in serum samples from chickens and horses, Guadeloupe, 
2002
a 
Species  Titer to WNV  Titer to SLEV  Interpretation 
Chicken  >640  <20  WNV 
Chicken  320  <60  WNV 
Chicken  160  <40  WNV 
Chicken  >640  20  WNV 
Horse  160  <20  WNV 
Horse  >640  <20  WNV 
Horse  40  <20  Flavivirus 
Horse  320  <20  WNV 
Horse  320  <20  WNV 
Horse  40  <20  Flavivirus 
Horse  160  <20  WNV 
Horse  160  <20  WNV 
Horse  <20  <20  Negative 
Horse  80  20  WNV 
aWNV, West Nile virus; SLEV, St. Louis encephalitis virus. 